| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2004 | CN1155567C Antipsychotic indolyl derivatives |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | CN1155410C Composition for treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| 06/30/2004 | CN1155409C Medical compsns. for preventing and treating arteriosclerotic desease |
| 06/30/2004 | CN1155408C Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies |
| 06/30/2004 | CN1155405C Recipe and prepn. of medicine for treating diabetic ulcer and preparation method |
| 06/30/2004 | CN1155403C Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 06/30/2004 | CN1155393C Application of 6-0-carboxymethyl chitosan in treating gastritis and gastric ulcer |
| 06/30/2004 | CN1155391C Novel immunosuppressants |
| 06/30/2004 | CN1155390C Application of N-gluco-N-bithiocarboxylic acid-L-amino acid sodium in repelling Pt |
| 06/30/2004 | CN1155389C Compound traditional medicine with piperine for increasing biological utilization of paeoniflorin and its preparing method |
| 06/30/2004 | CN1155388C Orally administrable solid ribavirin dosafe forms and process for making them |
| 06/30/2004 | CN1155387C Phosphonate medicine for treating osteoporosis and bone cancer transfer |
| 06/30/2004 | CN1155386C Nailpolish having function of resisting psoriasis |
| 06/30/2004 | CN1155385C Formulation comprising testosteron undecanoate and castor oil |
| 06/30/2004 | CN1155384C Cyclodextrin encapsulated freeze-dried powder injection of prostaglandin E1 and production technology thereof |
| 06/30/2004 | CN1155383C Use of certain isoquinolinesulfonyl compounds for treatment of glaucoma and ocular ischemia |
| 06/30/2004 | CN1155382C Tablet with controlled release of alfuzosine chlorydrate |
| 06/30/2004 | CN1155381C New pharmaceutical use of sinomenine |
| 06/30/2004 | CN1155380C Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis |
| 06/30/2004 | CN1155379C Use of Yiliqutan in preparing medicine for preventing recurrence of cephalagra |
| 06/30/2004 | CN1155378C Antitumour synergistic composition |
| 06/30/2004 | CN1155377C Anti-first-pass effect compounds |
| 06/30/2004 | CN1155376C 9-cis-retinonic acid and medicinal use of salt and ester thereof |
| 06/30/2004 | CN1155375C Linolic acid and linolenic acid capsule and its making process |
| 06/30/2004 | CN1155374C Novel biological activity of proglumide |
| 06/30/2004 | CN1155373C S-(3-hydroxypropyl)-L-cysteine composition as oral medicine |
| 06/30/2004 | CN1155372C Electrically assisted delivery conveyor and using method thereof |
| 06/30/2004 | CN1155370C Process for preparing medicinal granule |
| 06/30/2004 | CN1155369C Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 06/30/2004 | CA2454629A1 Amino acids in micelle preparation |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756518 Administering cross-linked polysaccharide having a positive charge as a wound healing agent and to reducing transforming growth factor activity |
| 06/29/2004 | US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production |
| 06/29/2004 | US6756508 Cinnamic acid salts, processes for their preparation, and their use as medicaments |
| 06/29/2004 | US6756507 Process for the preparation of sodium salts of statins |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756489 Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders |
| 06/29/2004 | US6756408 Methods and materials for protecting against myocardial cell damage related to coronary intervention by regional beta blocker therapy |
| 06/29/2004 | US6756407 Administering a compound which acts on a mid-brain pathway to increase blood flow in the ilio-hypogastric-pudendal arterial bed and genitalia |
| 06/29/2004 | US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 06/29/2004 | US6756405 Conjugated linoleic acid powder |
| 06/29/2004 | US6756404 Autoinducer compounds |
| 06/29/2004 | US6756403 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756399 Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents |
| 06/29/2004 | US6756398 Positive modulators of nicotinic receptor agonists |
| 06/29/2004 | US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756392 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -n-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756389 Pharmaceutically active compounds and methods of use |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 06/29/2004 | US6756386 Such as 1-methyl-3-oxy-(5-chloro-3-pyridyl)-piperidine; cholinergic system of central nervous system; pain, inflammation |
| 06/29/2004 | US6756383 Such as 3-(2-(methoxycarbonyl)acetylamino)pyridine-4-carboxylic acid for treatment of diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases; enzyme inhibitors |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756379 Non-sedating barbiturate compounds as neuroprotective agents |
| 06/29/2004 | US6756375 Estrogen receptor modulation; hormone replacement therapy |
| 06/29/2004 | US6756374 Diaminothiazoles having antiproliferative activity |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | US6756369 Administering to the patient at least two agents, each of which is effective against a different phase of chlamydial life cycle, until the biological material is negative for chlamydia |
| 06/29/2004 | US6756368 Having such as 1-imine-3-hydroxy-prop-1-ene and imidazole ligands; varicella-zoster, vesicular stomatitis, poliovirus, adenovirus |
| 06/29/2004 | US6756366 Orally active androgens |
| 06/29/2004 | US6756365 Reducing tetracycline resistance in living cells |
| 06/29/2004 | US6756364 Method of reducing gastrointestinal side effects associated with orlistat treatment |
| 06/29/2004 | US6756363 Solutions and films of glycated chitosan |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756360 Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
| 06/29/2004 | US6756359 Administering a 14 membered macrolide and ketolide antibiotics containing c12 modifications to a patient suffering from bacterial infections |
| 06/29/2004 | US6756354 Stabilization of drugs |
| 06/29/2004 | US6756208 Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756065 Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/29/2004 | US6756063 A dithiocarbonyl compound; a metal cation; a modulator of cellular glutathione levels; and an inhibitor of the phosphorylation of choline. |
| 06/29/2004 | US6756057 Sustained release bilayer tablet providing both immediate and time delayed delivery |
| 06/29/2004 | US6756055 Administering to a mammal formulation of cationic lipids and a substance that affects angiogenesis; allowing formulation to associate with angiogenic endothelial cells of an angiogenic blood vesselsuch that it enters cells |
| 06/29/2004 | US6756054 Cholesterol carbamylated to straight chain polyamine |
| 06/29/2004 | US6756053 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 06/29/2004 | US6756052 Effects localized increase in temperature and/or blood flow using rubefacient agent |
| 06/29/2004 | US6756051 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | US6756045 Topically applied idebenone-containing agent with protective and regenerative effect |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | US6756033 Method for delivering benzindene prostaglandins by inhalation |
| 06/29/2004 | US6756031 One or more of: polyacrylonitrile, polyvinylacetate, cellulose acetate butyrate, nitrocellulose and polycarbonateurethane copolymers and maleic acid-styrene copolymers; a contrast agent, and a biocompatible solvent |
| 06/29/2004 | CA2366304C Novel method of treatment |
| 06/29/2004 | CA2311391C Skin protection composition |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2293815C Film-coated tablet for improved upper gastrointestinal tract safety |
| 06/29/2004 | CA2285941C Process for enhancing immune response in animals using .beta.-carotene as a dietary supplement |